Access and Equity of Biopharmaceutical Therapies

GT Biopharma, Inc. (NASDAQ: GTBP) is a clinical stage immuno-oncology company focused on developing innovative therapies based on the Company's proprietary NK ... Oct 27, 2022 ... The Helix report argues that if companies are to make another leap forward, they may need to recalibrate their formula for success. May 23, 2024 ... AbbVie (NYSE: ABBV) announced today that it has completed its acquisition of Landos Biopharma, Inc. (NASDAQ: LABP). Caris Biopharma Solutions are designed to empower partners at every stage of the development cycle. With answers that enable more informed program decisions, ... Pioneering In Vivo CAR T Cell Therapies. We are committed to improving the treatment experience for patients through the development of better, faster, more ... We are a clinical-stage biopharmaceutical company dedicated to the identification, development and commercialization of differentiated medicines to address the ... Grove Biopharma is a multidisciplinary team of chemists, biologists, materials scientists, and entrepreneurs working together to advance a new synthetic drug ... Theravance Biopharma aims to transform the treatment of specialty respiratory and neurologic diseases through the discovery, development and commercialization ... Biologic is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Jan 30, 2025 ... A futuristic biopharma laboratory equipped with AI-powered data analysis tools, automated robotic lab equipment, and digital interfaces showcasing drug ...